Matthew A. Berger, MD

Matthew A. Berger, MD in Moosic, Pennsylvania offers Spravato for adults with treatment-resistant depression. The FDA-approved esketamine nasal spray is administered on site for patients who have had an inadequate response to two or more oral antidepressants.

Spravato is also indicated for adults with major depressive disorder experiencing suicidal thoughts or actions. The practice provides this treatment under medical supervision as part of its psychiatric care.

Patients can request information through the office, which follows up in a timely manner, and a patient starter guide is available to help explain the treatment process.